on 28 Sept 2022
TM5 Status
LIVE/REGISTRATION/Issued and Active
Your registration has been issued and is active. You can now use the TM5 mark.
Last Applicant/ Owned by
VESPYR BRANDS LLC
c/o Aurobindo Pharma USA, Inc.279 Princeton Highstown RoadEast Windsor, NJ 08520
US
Serial Number
2029839 filed on 21st May 2020
Registration Number
TMA1143621 registered on 28th Sept 2022
Registration expiry Date
28th Sept 2032Correspondent Address
BENNETT JONES LLP
SUITE 3400, ONE FIRST CANADIAN PLACEP.O. BOX 130TORONTO
ONTARIO
CA
M5X1A4
Trademark usage description
orally disintegrating tablets, orally disintegrating medicaments, and medicaments all for reducing the duration and severity of the common cold and sy Read More11
2029839
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 26 on 3rd May 2022 | Approved |
Submitted for opposition 135 on 15th Mar 2022 | Amendment to Application |
Submitted for opposition 135 on 31st Jan 2022 | Amendment to Application |
Submitted for opposition 22 on 16th Sept 2021 | Search Recorded |
Submitted for opposition 20 on 16th Sept 2021 | Examiner's First Report |
Submitted for opposition 80 on 1st Sept 2021 | Change of Title Registered |
Submitted for opposition 48 on 1st Sept 2021 | Agent Changed |
Submitted for opposition 30 on 21st May 2020 | Filed |
Submitted for opposition 1 on 21st May 2020 | Created |
Submitted for opposition 31 on 21st May 2020 | Formalized |
This website uses cookies
Manage cookies
You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.
Advertisement
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously
Analytics
Analytical cookies are used to understand how visitors interact with the website.
Functional
Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website.